Oregon 2025 Regular Session

Oregon House Bill HB3321

Introduced
1/21/25  
Refer
1/24/25  
Refer
2/20/25  
Refer
2/20/25  
Refer
5/6/25  
Refer
5/6/25  
Report Pass
6/19/25  
Engrossed
6/24/25  
Refer
6/24/25  
Report Pass
6/25/25  
Enrolled
6/25/25  
Passed
7/17/25  
Chaptered
8/7/25  

Caption

Relating to primary prevention of substance use.

Impact

If enacted, HB3321 would result in potential changes to state laws regarding public health and education, particularly in relation to programs aimed at preventing substance use disorders. The emphasis on prevention could lead to increased funding for educational initiatives and community programs designed to inform and empower residents, especially youth, about the risks associated with substance use. Additionally, the bill could influence how state resources are allocated toward substance use treatment and prevention efforts, marking a shift toward more holistic health and wellness strategies.

Summary

House Bill 3321 is focused on the primary prevention of substance use. It aims to implement policies and programs that will reduce the risk of substance use behaviors among individuals, particularly targeting vulnerable populations. By emphasizing prevention, the bill seeks to address substance abuse issues proactively rather than reactively, aiming to minimize long-term societal impacts and promote healthier communities. This approach is in line with a growing recognition of the importance of early intervention and education in tackling substance misuse.

Sentiment

The sentiment surrounding HB3321 appears to be generally supportive among health advocates and some legislators, who argue that prevention is key to reducing the incidence of substance use disorders in the state. Supporters believe that investing in prevention will not only save lives but also reduce the financial burdens that substance use places on the healthcare system and community resources. However, there are concerns from some stakeholders about the feasibility of the proposed measures and whether adequate funding will be secured for effective implementation.

Contention

The main contention surrounding HB3321 lies in the specifics of how prevention programs will be executed and funded. Critics express skepticism regarding the adequacy of funding and the potential for competing initiatives to divert resources away from substance use prevention. There is also a concern that without a robust evaluation mechanism, the effectiveness of the proposed programs might be difficult to measure, potentially leading to challenges in justifying continued support for these initiatives in the future. As discussions continue, the balance between preventive measures and practical implementation remains a critical focal point.

Companion Bills

No companion bills found.

Similar Bills

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MA H2227

Replacing archaic and stigmatizing language for substance use

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

MI HB4167

Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

MI HB4256

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25

MI SB0431

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25